Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer's Crizotinib Eases Past FDA With Targeted Population

Aug 26 2011

• By Mary Jo Laffler

Related Content

Fast As A Whip, Pfizer Files Personalized Lung Cancer Drug Crizotinib

Jan 12 2011

<i>Zelboraf</i> Approval Hastened By FDA Officials Impressed With Early Efficacy

Aug 22 2011

Survival Data For Pfizer's Crizotinib Appears Promising, Positioning It For Accelerated Approval

May 19 2011

NSCLC Market Snapshot: Promising Biomarkers, Testing Challenges

May 30 2011

Crizotinib Holds Promise For Lung Cancer, And For Pfizer Oncology

Jun 14 2010

FDA Releases Companion Dx Guidance Broad In Scope, Limited In Detail

Jul 18 2011

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window